AI vs. an analyst: Seven predictions about the future of the insight business

The arrival of artificial intelligence generally, and ChatGPT specifically, has generated a massive amount of discussion about both opportunities and potential threats. 

Amanda Berra
Amanda Berra
Updated Jul 19, 2024 14 min read

The arrival of artificial intelligence generally, and ChatGPT specifically, has generated a massive amount of discussion about both opportunities and potential threats. Within healthcare, the ChatGPT discussion has primarily focused on patient- and clinician-facing applications, with aims such as achieving scale in primary care, reducing the burden of clinical documentation, and facilitating clinical research.

Less has been written about the business side of healthcare, where presumably ChatGPT could be no less of an essential tool, as well as causing new problems. For a research/knowledge/insights-driven business such as Union, the opportunity would clearly be to drastically improve efficiency in the research process. The worries range from the immediate (what quality of the information does this tool generate?) to the existential (is human expert-led research about to be drowned out by a flood of AI-generated content?)

To gain some first-hand experience, I spent time putting the tool through its paces, quizzing it about healthcare strategy research-type topics such as the role of private equity in healthcare, Medicare program mechanics, players in the life science industry, the pharmacy value chain, and some hard-to-find info about provider contract rates—topics that overlapped with live projects I am currently working on.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.